ZELTIQ Aesthetics (ZLTQ) Receives Analyst Rating

ZELTIQ Aesthetics (ZLTQ) : 8 brokerage houses believe that ZELTIQ Aesthetics (ZLTQ) is a Strong Buy at current levels. Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 8 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.

ZELTIQ Aesthetics (ZLTQ) : The most positive equity analysts on ZELTIQ Aesthetics (ZLTQ) expects the shares to touch $48, whereas, the least positive believes that the stock will trade at $38 in the short term. The company is covered by 7 Wall Street Brokerage Firms. The average price target for shares are $43.43 with an expected fluctuation of $4.47 from the mean.


Also, Equity analysts at the Brokerage firm JP Morgan maintains its rating on ZELTIQ Aesthetics (NASDAQ:ZLTQ). The rating major has initiated the coverage with neutral rating on the shares. The Analysts at JP Morgan raises the price target from $27 per share to $35 per share. The rating by the firm was issued on August 9, 2016.

ZELTIQ Aesthetics (NASDAQ:ZLTQ): After opening at $39.23, the stock dipped to an intraday low of $38.75 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $40.59 and the buying power remained strong till the end. The stock closed at $40.14 for the day, a gain of 1.90% for the day session. The total traded volume was 750,303. The stocks close on the previous trading day was $39.39.

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.